Danielle Fishel raises awareness of Stage 0 breast cancer diagnosis

Stage 0 breast cancer, also known as ductal carcinoma in situ (DCIS), is a condition where abnormal cells are found in the milk ducts of the breast but have not spread to surrounding tissues. This diagnosis is becoming more common, particularly among older women, due to increased screening through mammograms. In 2024, nearly 100,000 cases of DCIS are expected in the U.S., highlighting the importance of regular screenings starting at age 40 or 45. Danielle Fishel's recent diagnosis of high-grade DCIS has brought attention to this condition, which can sometimes extend into adjacent tissues. While many women diagnosed with DCIS may not require aggressive treatment, the psychological impact of monitoring the condition can be significant. Some patients may undergo radiation or hormone therapy to reduce the risk of recurrence, but the effectiveness of these treatments can vary. Research indicates that not all cases of DCIS will progress to invasive cancer, and some may remain non-invasive throughout a patient's life. This raises questions about the necessity of immediate treatment for all patients diagnosed with DCIS. Active monitoring could be a viable alternative for low-risk cases, but it also introduces anxiety for patients who may feel uncertain about their health. Ultimately, the awareness raised by Fishel's diagnosis emphasizes the need for women to engage in regular screenings and understand their options. The medical community continues to explore the best approaches to managing DCIS, balancing treatment benefits with the psychological effects of living with a cancer diagnosis.